Icon Cancer Centre Mount Alvernia

Singapore 228510

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Gastric Cancer, Head and Neck Cancer, Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Resectable Non-Small-Cell Lung Cancer, Solid Tumor, Urothelial Carcinoma

Studies at this site

• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling